A double-blind, placebo-controlled study of vigabatrin three g/day in patients with uncontrolled complex partial seizures. Vigabatrin Protocol 024 Investigative Cohort.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples